Sellas Life Sciences Group IncHealthcare | Biotechnology
SELLAS Life Sciences Group Inc. is an advanced-stage biopharmaceutical company headquartered in New York, dedicated to developing innovative cancer immunotherapies aimed at addressing a range of oncological indications. With a strategic focus on harnessing the body's immune system to target and fight cancer, Sellas is actively advancing its proprietary pipeline to meet the urgent needs of patients. The company’s commitment to transforming cancer treatment positions it as a key player in the evolving biopharmaceutical landscape.
Click "Analyze" to generate stock analysis
SLS Price Trend and Signals
SLS Option Volumes & Open Interests (aggregated)
SLS Put Call Ratios and IV (aggregated)
SLS Financials
2025-10-23Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-20Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-20Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-20Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.
2025-10-15Somewhat Bullishprice_signal
Quarterly high detected.
2025-10-14Somewhat Bullishprice_signal
Quarterly high detected.
2025-10-14Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-10-14Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-10-14Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-10-14Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.